CA2253796A1 - Inhibition de metalloproteases matricielles par des composes contenant de l'acetylene - Google Patents
Inhibition de metalloproteases matricielles par des composes contenant de l'acetyleneInfo
- Publication number
- CA2253796A1 CA2253796A1 CA002253796A CA2253796A CA2253796A1 CA 2253796 A1 CA2253796 A1 CA 2253796A1 CA 002253796 A CA002253796 A CA 002253796A CA 2253796 A CA2253796 A CA 2253796A CA 2253796 A1 CA2253796 A1 CA 2253796A1
- Authority
- CA
- Canada
- Prior art keywords
- compounds
- disease
- conditions
- pharmaceutical compositions
- matrix metalloproteases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 102000005741 Metalloproteases Human genes 0.000 title abstract 3
- 108010006035 Metalloproteases Proteins 0.000 title abstract 3
- 239000011159 matrix material Substances 0.000 title abstract 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 title 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- 208000025494 Aortic disease Diseases 0.000 abstract 1
- 206010053555 Arthritis bacterial Diseases 0.000 abstract 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 abstract 1
- 206010053177 Epidermolysis Diseases 0.000 abstract 1
- 208000004575 Infectious Arthritis Diseases 0.000 abstract 1
- 208000012659 Joint disease Diseases 0.000 abstract 1
- 206010060820 Joint injury Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010064996 Ulcerative keratitis Diseases 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 208000002528 coronary thrombosis Diseases 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 201000001474 proteinuria Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 201000001223 septic arthritis Diseases 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64502896A | 1996-05-15 | 1996-05-15 | |
| US08/645,028 | 1996-05-15 | ||
| PCT/US1997/007921 WO1997043245A1 (fr) | 1996-05-15 | 1997-05-12 | Inhibition de metalloproteases matricielles par des composes contenant de l'acetylene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2253796A1 true CA2253796A1 (fr) | 1997-11-20 |
| CA2253796C CA2253796C (fr) | 2003-10-28 |
Family
ID=24587368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002253796A Expired - Fee Related CA2253796C (fr) | 1996-05-15 | 1997-05-12 | Inhibition de metalloproteases matricielles par des composes contenant de l'acetylene |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0912496A1 (fr) |
| JP (1) | JP3090957B2 (fr) |
| CN (1) | CN1139570C (fr) |
| AR (1) | AR007097A1 (fr) |
| AU (1) | AU710759B2 (fr) |
| BR (1) | BR9709077A (fr) |
| CA (1) | CA2253796C (fr) |
| CO (1) | CO5080759A1 (fr) |
| HN (1) | HN1997000088A (fr) |
| HR (1) | HRP970245B1 (fr) |
| ID (1) | ID16910A (fr) |
| PA (1) | PA8429301A1 (fr) |
| SV (1) | SV1997000035A (fr) |
| TN (1) | TNSN97084A1 (fr) |
| TW (1) | TW381079B (fr) |
| WO (1) | WO1997043245A1 (fr) |
| YU (1) | YU18697A (fr) |
| ZA (1) | ZA974031B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6288063B1 (en) | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
| US6326516B1 (en) | 1999-01-27 | 2001-12-04 | American Cyanamid Company | Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors |
| AR035478A1 (es) * | 1999-01-27 | 2004-06-02 | Wyeth Corp | Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene |
| EP1031349A1 (fr) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Utilisation d'acides 4-biarylbutyriques et 5-biarylpentanoiques substitués pour traiter les maladies cérébrales |
| US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
| ES2592154T3 (es) | 2010-07-08 | 2016-11-28 | Kaken Pharmaceutical Co., Ltd. | Derivado de N-hidroxiformamida y medicamento que contiene el mismo |
| US20170119776A1 (en) | 2014-04-03 | 2017-05-04 | Bayer Pharma Aktiengesellschaft | Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof |
| CA2944614A1 (fr) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | Acides cyclopentanecarboxyliques a disubstitution 2,5 pour traiter des maladies des voies respiratoires |
| WO2015150363A1 (fr) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | Acides cyclopentanecarboxyliques à disubstitution 2,5 et leur utilisation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
| DE2112716A1 (de) * | 1971-03-17 | 1972-10-05 | Thomae Gmbh Dr K | Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
-
1997
- 1997-05-09 CO CO97025172A patent/CO5080759A1/es unknown
- 1997-05-09 ZA ZA9704031A patent/ZA974031B/xx unknown
- 1997-05-09 TN TNTNSN97084A patent/TNSN97084A1/fr unknown
- 1997-05-09 HR HR970245A patent/HRP970245B1/xx not_active IP Right Cessation
- 1997-05-12 PA PA19978429301A patent/PA8429301A1/es unknown
- 1997-05-12 YU YU18697A patent/YU18697A/sr unknown
- 1997-05-12 AR ARP970101977A patent/AR007097A1/es unknown
- 1997-05-12 HN HN1997000088A patent/HN1997000088A/es unknown
- 1997-05-12 CN CNB971964564A patent/CN1139570C/zh not_active Expired - Fee Related
- 1997-05-12 SV SV1997000035A patent/SV1997000035A/es unknown
- 1997-05-12 TW TW086106283A patent/TW381079B/zh not_active IP Right Cessation
- 1997-05-12 JP JP09540980A patent/JP3090957B2/ja not_active Expired - Fee Related
- 1997-05-12 BR BR9709077A patent/BR9709077A/pt not_active Application Discontinuation
- 1997-05-12 EP EP97923622A patent/EP0912496A1/fr not_active Withdrawn
- 1997-05-12 WO PCT/US1997/007921 patent/WO1997043245A1/fr not_active Application Discontinuation
- 1997-05-12 AU AU29386/97A patent/AU710759B2/en not_active Ceased
- 1997-05-12 CA CA002253796A patent/CA2253796C/fr not_active Expired - Fee Related
- 1997-05-14 ID IDP971606A patent/ID16910A/id unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA974031B (en) | 1998-02-19 |
| TW381079B (en) | 2000-02-01 |
| PA8429301A1 (es) | 2000-05-24 |
| ID16910A (id) | 1997-11-20 |
| BR9709077A (pt) | 1999-08-03 |
| AR007097A1 (es) | 1999-10-13 |
| JPH11511179A (ja) | 1999-09-28 |
| HN1997000088A (es) | 1997-06-18 |
| YU18697A (en) | 1999-11-22 |
| HRP970245B1 (en) | 2002-06-30 |
| JP3090957B2 (ja) | 2000-09-25 |
| CN1139570C (zh) | 2004-02-25 |
| CO5080759A1 (es) | 2001-09-25 |
| AU2938697A (en) | 1997-12-05 |
| HRP970245A2 (en) | 1998-04-30 |
| SV1997000035A (es) | 1999-01-14 |
| TNSN97084A1 (fr) | 2005-03-15 |
| CA2253796C (fr) | 2003-10-28 |
| AU710759B2 (en) | 1999-09-30 |
| CN1225623A (zh) | 1999-08-11 |
| WO1997043245A1 (fr) | 1997-11-20 |
| EP0912496A1 (fr) | 1999-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2254731A1 (fr) | Inhibition des metalloproteases matricielles par les acides 2-substitues-4-(4-phenylesubstitue)-4-oxobutyriques | |
| CA2253796A1 (fr) | Inhibition de metalloproteases matricielles par des composes contenant de l'acetylene | |
| IL110216A0 (en) | Valproic acid amide and 2-valproenoic acid amide derivatives, their preparation and pharmaceutical compositions containing them | |
| DE69330949D1 (de) | Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie | |
| PT895988E (pt) | Derivados do acido arilsulfonilamino-hidroxamico | |
| IL115745A0 (en) | Acylated benzylglycosides and pharmaceutical compositions containing them | |
| YU67900A (sh) | Sukcinamidni inhibitori interleukin-1beta konvertujućeg enzima | |
| CA2253870A1 (fr) | Inhibition de metalloproteases matricielles par des composes de phenetyle substitues | |
| DE69005974D1 (de) | Heteroaryl-3-oxo-propannitril-derivate, nützlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten. | |
| CA2254750A1 (fr) | Inhibition de metalloproteases matricielles par des acides 2-(.omega.-aroylalkyl)-4-biaryl-4-oxobutyriques | |
| EP0842933A4 (fr) | Nouveaux derives de naphtyridine | |
| PT826681E (pt) | Derivados de acido epoxi-succinico | |
| HU9400094D0 (en) | New 17,20-epoxy-pregnane derivatives process for producing them and use of them for producing cortizone derivatives and intermadeiates | |
| AR007096A1 (es) | Compuesto inhibidor de la metaloproteasa de matriz metodo para inhibir su actividad, una composicion que lo contiene y uso de dichos compuestos para preparar composiciones farmaceuticas | |
| ECSP972112A (es) | Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido | |
| ECSP972114A (es) | Biarilacetilenos como inhibidores de la metaloproteasa de matriz | |
| JPH07196598A (ja) | ヒドロキサム酸誘導体およびそれを有効成分とする医薬組成物 | |
| EP0322183A3 (en) | Products and methods of inhibiting corrosion | |
| AU3322997A (en) | A method for treating allergic and inflammatory diseases and for inhibiting the production of tumor necrosis factor | |
| ECSP972111A (es) | Inhibidores de la metaloproteinasas de matriz por acidos 2-(aroilalquil)-4 biaril-4- oxobutiricos | |
| ECSP972115A (es) | Acidos oxibutiricos sustituidos como inhibidores de la metaloproteasa de matriz | |
| WO2000019989A3 (fr) | Utilisation de derives de catechine comme inhibiteurs de proteinase | |
| ECSP972113A (es) | Inhibicion de las metaloproteasas de matriz por acidos biariloxobutiricos sustituidos | |
| TH12333B (th) | การยับยั้งแมทริกซ์เมธัลลอโปรตีเนสโดยสารประกอบซับสทิทิวเทดเฟเนธิล | |
| MY113474A (en) | High temperature corrosion inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |